Fortis Malar Hospitals Share Price

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	0.52	0.54	4.63	0.77	0.56
Total Income Growth (%)	-3.43	-88.28	503.11	36.92	0.57
Total Expenses	0.33	0.40	0.34	0.37	0.41
Total Expenses Growth (%)	-16.04	16.04	-7.53	-9.39	-12.72
EBIT	0.19	0.14	4.28	0.40	0.15
EBIT Growth (%)	31.30	-96.63	980.41	162.13	70.96
Profit after Tax (PAT)	0.02	0.01	4.15	0.36	0.01
PAT Growth (%)	8.45	-99.66	1,051.93	0.00	-91.28
EBIT Margin (%)	36.21	26.63	92.59	51.69	27.00
Net Profit Margin (%)	2.94	2.62	89.74	46.98	1.37
Basic EPS (₹)	0.01	0.01	2.22	0.19	0.00

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	0.52	0.52	4.61	0.77	0.56
Total Income Growth (%)	0.75	-88.77	500.44	36.92	0.57
Total Expenses	0.31	0.37	0.30	0.37	0.40
Total Expenses Growth (%)	-15.28	22.98	-19.26	-8.44	-12.90
EBIT	0.21	0.15	4.31	0.40	0.16
EBIT Growth (%)	39.97	-96.52	983.68	153.90	67.31
Profit after Tax (PAT)	0.04	0.02	4.18	0.36	0.01
PAT Growth (%)	80.40	-99.52	1,054.69	2,682.31	-86.08
EBIT Margin (%)	40.32	29.02	93.52	51.82	27.94
Net Profit Margin (%)	6.89	3.85	90.65	47.14	2.32
Basic EPS (₹)	0.02	0.01	2.23	0.19	0.01

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2.72	65.96	92.59	93.57	77.50
Total Revenue Growth (%)	-95.88	-28.76	-1.05	20.74	-37.03
Total Expenses	2.15	73.88	99.60	101.83	95.66
Total Expenses Growth (%)	-97.09	-25.82	-2.19	6.46	-29.14
Profit after Tax (PAT)	0.39	45.32	-15.48	-8.27	-7.87
PAT Growth (%)	-99.14	-	-	-	-
Operating Profit Margin (%)	0.00	-6.12	-1.09	-1.97	-15.82
Net Profit Margin (%)	0.00	76.81	-18.01	-9.60	-11.36
Basic EPS (₹)	0.21	24.18	-8.26	-4.41	-4.20

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2.72	67.88	92.51	93.51	77.33
Total Revenue Growth (%)	-96.00	-26.62	-1.07	20.93	-37.03
Total Expenses	2.13	73.86	99.59	101.82	95.64
Total Expenses Growth (%)	-97.11	-25.83	-2.19	6.46	-29.13
Profit after Tax (PAT)	0.41	47.28	-15.53	-8.31	-8.01
PAT Growth (%)	-99.13	-	-	-	-
Operating Profit Margin (%)	0.00	-2.84	-1.17	-2.02	-16.05
Net Profit Margin (%)	0.00	80.11	-18.07	-9.63	-11.57
Basic EPS (₹)	0.22	25.23	-8.29	-4.43	-4.28

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 133.8% outperformed its 3 year CAGR of -58.69%. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	36.83	115.88	138.00	160.91	169.10
Total Assets Growth (%)	-68.21	-16.03	-14.24	-4.84	-12.63
Total Liabilities	-	-	73.83	80.78	80.35
Total Liabilities Growth (%)	-	-100.00	-8.61	0.53	-17.28
Total Equity	30.21	109.47	64.17	80.13	88.74
Total Equity Growth (%)	-72.40	70.59	-19.92	-9.71	-7.95
Current Ratio (x)	5.15	17.68	2.66	1.56	2.43
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	10.60	-	-	-	-

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	36.57	115.39	135.69	158.67	166.99
Total Assets Growth (%)	-68.31	-14.96	-14.48	-4.98	-12.76
Total Liabilities	6.61	6.18	73.73	80.70	80.37
Total Liabilities Growth (%)	6.96	-91.62	-8.64	0.41	-17.13
Total Equity	29.96	109.21	61.96	77.97	86.62
Total Equity Growth (%)	-72.57	76.26	-20.53	-9.99	-8.27
Current Ratio (x)	5.15	18.28	2.60	1.50	2.35
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	10.60	-	-	-	-

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1.54	-7.30	5.61	6.84	-0.86
Net Cash used in Investing Activities	-29.10	119.70	0.50	8.23	-27.51
Net Cash flow from Financing Activities	-79.65	-10.85	-12.65	-10.10	-7.25
Net Cash Flow	-107.21	101.55	-6.54	4.98	-35.62
Closing Cash & Cash Equivalent	0.20	107.41	5.86	12.40	7.43
Closing Cash & Cash Equivalent Growth (%)	-99.81	1,732.70	-52.75	66.98	-82.75
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1.77	-7.21	5.61	6.80	-1.20
Net Cash used in Investing Activities	-27.30	119.62	0.43	8.18	-27.60
Net Cash flow from Financing Activities	-79.65	-10.85	-12.65	-10.10	-7.25
Net Cash Flow	-105.18	101.56	-6.61	4.87	-36.05
Closing Cash & Cash Equivalent	0.11	105.29	3.73	10.33	5.46
Closing Cash & Cash Equivalent Growth (%)	-99.90	2,722.96	-63.91	89.24	-86.84
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 0.62 cr is 0.15 times compared to the reported net profit of Rs 4.14 cr. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	1.29	41.40	-24.12	-10.32	-8.86
Return on Capital Employed (%)	1.91	-3.29	-0.88	-1.31	-7.59
Return on Assets (%)	1.06	39.11	-11.21	-5.14	-4.65
Interest Coverage Ratio (x)	56.70	1.34	1.85	1.65	-1.52
Asset Turnover Ratio (x)	-	0.46	0.58	0.53	40.94
Price to Earnings (x)	357.14	1.93	-5.78	-13.09	-13.23
Price to Book (x)	4.56	0.80	1.39	1.35	1.17
EV/EBITDA (x)	207.33	-3.62	7.14	8.83	47.25
EBITDA Margin (%)	0.00	9.74	13.04	12.56	2.76

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	1.36	43.29	-25.07	-10.65	-9.25
Return on Capital Employed (%)	1.98	-1.53	-0.96	-1.37	-7.81
Return on Assets (%)	1.12	40.97	-11.44	-5.23	-4.79
Interest Coverage Ratio (x)	58.44	1.79	1.84	1.64	-1.54
Asset Turnover Ratio (x)	-	0.47	0.58	0.53	41.46
Price to Earnings (x)	344.83	1.85	-5.76	-13.04	-12.99
Price to Book (x)	4.60	0.80	1.44	1.39	1.20
EV/EBITDA (x)	201.30	-2.43	7.37	9.05	52.53
EBITDA Margin (%)	0.00	13.02	12.96	12.51	2.54

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 12.04% in year ending Mar 31, 2026 outperforming its 5 year avg. of 8.2%. (Source: Consolidated Financials)

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Fortis Malar	23.26	2.80	12.04	13.75	11.00	-58.69	9,248.53	8,096.67	2.21	11.33	0.00	0.00
KMC Speciality	41.86	9.30	22.20	24.64	14.07	24.79	23.32	15.28	2.87	1.90	0.34	0.90
Lotus Eye Hosp	3,468.64	4.64	0.13	1.10	0.09	4.39	1.50	0.14	0.04	1.22	0.19	3.64
ANG Lifesciences Ind	-3.56	0.75	-20.95	-8.47	-5.30	-25.67	-5.46	-11.93	-8.43	1.00	1.47	7.03
Soni Medicare	-11.50	-25.26	0.00	-12.91	-10.14	-2.68	-5.76	-10.95	-5.94	1.13	-10.49	-21.51
Add More

Annual Ratios (%)

Choose from Peers

Chennai Multi
Tejnaksh Healthcare
Dolphin Medical
Looks Health Services
Dhanvantri Jeev

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Fortis Malar Stock Performance	-3.96	-3.28	-9.33	-5.97	-31.23	2.41	-20.09
KMC Speciality Stock Performance	2.04	26.29	32.91	41.89	73.54	100.92	192.92
Lotus Eye Hosp Stock Performance	10.50	24.57	20.81	14.32	80.51	77.62	162.94
ANG Lifesciences Ind Stock Performance	0.66	9.74	12.52	24.38	-3.48	-61.51	-59.52
Soni Medicare Stock Performance	0.00	0.00	0.00	10.62	6.82	263.00	138.17
Add More

Category	No. of Shares	Percentage
Promoters	1,17,52,402	62.71 %
Pledge	0	0.00 %
DII	13,500	0.07 %
MF	13,500	0.07 %
Others	69,75,857	37.22 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	62.71	62.71	62.71	62.71
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.07	0.07	0.07	0.07
Mutual Funds	0.07	0.07	0.07	0.07
Others	37.22	37.22	37.22	37.22

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 11, 2026
General Meeting
-
Feb 25, 2026
Board Meeting
Quarterly Results
Jan 30, 2026

Board Meetings

Announced on	Meeting on
May 11, 2026	May 18, 2026
Audited Results
Jan 30, 2026	Feb 06, 2026
Quarterly Results
Oct 29, 2025	Nov 06, 2025
Quarterly Results
Jul 28, 2025	Aug 04, 2025
Quarterly Results
May 07, 2025	May 15, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 17, 2024 Jul 24, 2024 25%
Apr 01, 2024 Apr 23, 2024 400%
Apr 29, 2015 Sep 14, 2015 5%
Aug 30, 2013 Sep 19, 2013 5%
May 24, 2016 - 5%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Mar 16, 1995 Apr 07, 1995
Rights ratio: 1 share for every 3 held at a price of Rs 10.0
AGM/EGM Meetings
Announced on Meeting on
Feb 25, 2026 Mar 29, 2026
-
Jul 04, 2025 Jul 30, 2025
-
Dec 13, 2024 Jan 13, 2025
-
Jul 10, 2024 Jul 31, 2024
-
Dec 04, 2023 Jan 05, 2024
-

Announced on	Ex-Date	Dividend%
May 17, 2024	Jul 24, 2024	25%
Apr 01, 2024	Apr 23, 2024	400%
Apr 29, 2015	Sep 14, 2015	5%
Aug 30, 2013	Sep 19, 2013	5%
May 24, 2016	-	5%

Announced on	Ex-Date
Mar 16, 1995	Apr 07, 1995
Rights ratio: 1 share for every 3 held at a price of Rs 10.0

Announced on	Meeting on
Feb 25, 2026	Mar 29, 2026
-
Jul 04, 2025	Jul 30, 2025
-
Dec 13, 2024	Jan 13, 2025
-
Jul 10, 2024	Jul 31, 2024
-
Dec 04, 2023	Jan 05, 2024
-

About Fortis Malar

Fortis Malar Hospitals Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 96.22 Crore) operating in Hospitals & Allied Services sector.

Fortis Malar Hospitals Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs .66 Crore, up 25.94 % from last quarter Total Income of Rs .52 Crore and down 14.06 % from last year same quarter Total Income of Rs .77 Crore. Company has reported net profit after tax of Rs -.04 Crore in latest quarter.

The company’s top management includes Mr.Daljit Singh, Mr.Chandrasekar Ramasamy, Ms.Richa Singh Debgupta, Dr.Ritu Garg, Ms.Shailaja Chandra, Ms.Suvalaxmi Chakraborty, Mr.Pradeep Kumar Malhotra, Ms.Vinti Verma. Company has B S R & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 1.87 Crore shares outstanding.

Fortis Malar Share Price Today is Rs. 51.34. On previous day, the Fortis Malar Share Price (NSE) closed at Rs. 53.46, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 62.71% of the stake in Fortis Malar shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Fortis Malar stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.07% as compared to 0.07% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Fortis Malar shares 0.07% was held by mutual funds. The rest including public held is 0.0%. Fortis Malar stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Fortis Malar Dividend: Ever since 1989, Fortis Malar dividends has been paid out around 7 times. As on 11 Jun, 2026, 03:52 PM IST, The overall dividend yield for Fortis Malar stands at 0.0%. The last dividend paid was on July 24, 2024 (Rs. 2.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 2.21.

Fortis Malar Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 0.66 Cr. of sales and 25.94% of quarterly net profit, there have been multiple ups and downs in the Fortis Malar stock prices in the past few weeks. For example, Fortis Malar stock price on 4th of June 2026 was around Rs. 54.36. Fortis Malar share price now stands at an average of Rs. 51.34. Judging by last week's performance, stock is in down trend.

Fortis Malar has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Fortis Malar share.

Historical Prices and Performance:
Fortis Malar, incorporated in 1989 is a Small Cap company (with a market cap of Rs. 96.22) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Fortis Malar stock was 12.04%, 1.29%, 41.4%, -24.12% and -10.32% respectively.
The Fortis Malar share gave a 3 year return of 1.46% as compared to Nifty 50 which gave a return of 24.77%.
Fortis Malar announced 25.0% final dividend on July 24, 2024.

Key Metrics:
PE Ratio of Fortis Malar is 24.24
Prices/Sales Ratio of Fortis Malar is 1544.07
Price/Book Ratio of Fortis Malar is 2.92

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 24.24 and 2.92 respectively.

Leadership of Fortis Malar :
Pradeep Kumar Malhotra is Chief Financial Officer
Vinti Verma is Co. Secretary & Compl. Officer
Daljit Singh is Chairman (Non - Executive) & Non Independent Direc
Chandrasekar Ramasamy is Whole Time Director
Richa Singh Debgupta is Non Exe.Non Ind.Director
Shailaja Chandra is Independent Director
Suvalaxmi Chakraborty is Independent Director
Ritu Garg is Non Exe.Non Ind.Director

Industry

Hospital

Key Indices Listed On

-

Address

Fortis Hospital,Sector 62,Phase - VIII,Mohali, Punjab - 160062

Contact

secretarial.malar@malarhospitals.in

http://www.fortismalarhospital.com

PE Ratio(x)	23.26
EPS - TTM(₹)	2.21
MCap(₹ Cr.)	96.22
MCap Rank	33
PB Ratio(x)	2.92
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	77.00
52W Low(₹)	40.75
MCap/Sales	1,544.07
Beta(1 Month)	0.55
BV/Share(₹)	18.33

1 Day	-3.96%
1 Month	-6.96%
3 Months	-0.5%
1 Year	-30.63%
3 Years	1.56%
5 Years	-24.11%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Fortis Malar Hospitals Share Price

Key Metrics

Fortis Malar share price insights

Fortis Malar Share Price Returns

Fortis Malar Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Fortis Malar Top Searches

Corporate Actions

About Fortis Malar

Executive Leadership

Auditors

FAQs about Fortis Malar share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News